Contribution of coagulases towards Staphylococcus aureus disease and protective immunity

Alice G Cheng1, Molly McAdow, Hwan K Kim

  • 1Department of Microbiology, University of Chicago, Chicago, Illinois, United States of America.

Plos Pathogens
|August 12, 2010
PubMed

Insights

Staphylococcus aureus uses coagulase (Coa) and von Willebrand factor binding protein (vWbp) to form protective abscesses. Antibodies against these bacterial factors prevent abscesses and lethal infections, indicating their vaccine potential.

Area of Science:

  • Microbiology and Immunology
  • Bacterial Pathogenesis
  • Vaccine Development

Background:

  • Staphylococcus aureus forms abscesses, creating a protected niche shielded by a pseudocapsule.
  • Abscesses contain host-derived prothrombin and fibrin, crucial for lesion development.

Purpose of the Study:

  • To investigate the role of Staphylococcus aureus secreted factors, coagulase (Coa) and von Willebrand factor binding protein (vWbp), in abscess formation.
  • To evaluate the potential of Coa and vWbp as vaccine targets against S. aureus infections.

Main Methods:

  • Histochemical staining to identify prothrombin and fibrin in abscesses.
  • Assays to determine the function of Coa and vWbp in prothrombin activation and fibrinogen cleavage.
  • Administration of specific antibodies against Coa and vWbp to assess protection against abscess formation and bacteremia in vivo.

Main Results:

  • Coa and vWbp were identified as essential for Staphylococcus aureus abscess formation.
  • These factors promote non-proteolytic activation of prothrombin and cleavage of fibrinogen.
  • Specific antibodies against Coa and vWbp effectively inhibited abscess development and lethal bacteremia.

Conclusions:

  • Staphylococcus aureus utilizes Coa and vWbp to manipulate host clotting factors for abscess development.
  • Coa and vWbp represent promising protective antigens for the development of a Staphylococcus aureus vaccine.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.1K
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
80
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
150
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
106
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
45